Skip to main content
Premium Trial:

Request an Annual Quote

DCN, Asahi Kasei Fibers Partner on Nanobeads for Assay Development

NEW YORK (GenomeWeb News) – DCN Diagnostics today announced a deal with Asahi Kasei Fibers for the distribution of Asahi's cellulose nanobead product in North America.

Additionally, DCN, formerly called Diagnostic Consulting Network, will be the preferred provider of original equipment manufacturing services to users of Asahi's product, called NanoAct, worldwide, except in Japan, where Asahi is based.

NanoAct products comprise a range of high-intensity colored beads, which can be multiplexed. They generate higher sensitivity, lower coefficients of variation, and better stability than other visual labels such as colloidal gold, DCN said.

"We believe that NanoAct will allow for the development of higher performing lateral flow tests," CDN President Brendan O'Farrell said in a statement. "Coupled with DCN's assay development, training and customer support capabilities, we believe that this product line will allow for product performance that can have significant impact in many markets."

Financial and other terms were not disclosed.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.